Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |